Search - tctmd.com

Displaying 41 - 60 of 311

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1334: Transcarotid Treatment of Acute Ischemic Stroke

Presenter: Bekhzod Alimkhanov

October 28, 2024

Presentation TCT 2024

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

Presenter: Mauro Gitto

October 27, 2024

Presentation TCT 2024

TCT 1351: Cangrelor in a Challenging Scenario of Concomitant Ischemic Stroke, Pulmonary Embolism and STEMI

Presenter: Federico Oliveri

October 27, 2024

Presentation TCT 2024

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

Presenter: Jeehoon Kang

October 27, 2024

Presentation Fellows 2024

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

Presenter: Ajay J. Kirtane

April 12, 2024

Presentation ACC 2024

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

Presenter: C. Michael Gibson

April 06, 2024

Presentation THT 2024

CMR in Ischemic Cardiomyopathy

Presenter: Jonathan Weinsaft

March 05, 2024

Presentation THT 2024

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Presenter: Daniel Asemota

March 05, 2024

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

Presentation THT Abstracts 2024

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Presenter: Carl Pepine

March 04, 2024

Presentation THT Abstracts 2024

Three-Dimensional Morphological Analysis por Percutaneous Closure Candidate Selection and In-Hospital Mortality Prediction in Ischemic Ventricular Septal Ruptures

Presenter: Eduardo Arias

March 04, 2024

Presentation CTO 2024

Ischemic Cardiomyopathy: When and How Should I Revascularize?

Presenter: Jason Wollmuth

February 02, 2024

Presentation TCT 2023

High-risk PFO in a Patient With AF and Ischemic Stroke: Is There a Role for PFO Closure?

Presenter: Safwan Kassas

October 26, 2023

Presentation TCT 2023

TCT 104: Prognostic Impact of Ischemic Territory and Revascularization Strategy in Acute Myocardial Infarction Complicating Cardiogenic Shock Patients with Multi-vessel Disease

Presenter: Sangyoon Lee

October 26, 2023

Presentation TCT 2023

TCT 741: Clinical Outcomes of Ischemic Cardiomyopathy vs. Non-Ischemic Cardiomyopathy in Women with Left Ventricular Assist Device

Presenter: Priyadarshini Dixit

October 25, 2023

Presentation TCT 2023

TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions

Presenter: Eva Woelders

October 25, 2023

Presentation TCT 2023

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

Presenter: Cole Clifford

October 25, 2023

Presentation TCT 2023

TCT 615: Incorporation of Automated Robotic Transcranial Doppler to Screen for PFO and Quantify Right to Left Shunt Severity in the Evaluation of Ischemic Stroke Patients for Stroke Etiology at a Comprehensive Stroke Center

Presenter: Ira Chang

October 24, 2023

Presentation TCT 2023

Predicting Ischemic and Bleeding Risk in Patients after PCI on DAPT: An Individualized Patient Centered Machine Learning Model

Presenter: Roxana Mehran

October 24, 2023

Presentation Fellows 2023

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

Presenter: Ajay Kirtane

May 11, 2023

Advertisement

TCT 1334: Transcarotid Treatment of Acute Ischemic Stroke

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

TCT 1351: Cangrelor in a Challenging Scenario of Concomitant Ischemic Stroke, Pulmonary Embolism and STEMI

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

CMR in Ischemic Cardiomyopathy

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Three-Dimensional Morphological Analysis por Percutaneous Closure Candidate Selection and In-Hospital Mortality Prediction in Ischemic Ventricular Septal Ruptures

Ischemic Cardiomyopathy: When and How Should I Revascularize?

High-risk PFO in a Patient With AF and Ischemic Stroke: Is There a Role for PFO Closure?

TCT 104: Prognostic Impact of Ischemic Territory and Revascularization Strategy in Acute Myocardial Infarction Complicating Cardiogenic Shock Patients with Multi-vessel Disease

TCT 741: Clinical Outcomes of Ischemic Cardiomyopathy vs. Non-Ischemic Cardiomyopathy in Women with Left Ventricular Assist Device

TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

TCT 615: Incorporation of Automated Robotic Transcranial Doppler to Screen for PFO and Quantify Right to Left Shunt Severity in the Evaluation of Ischemic Stroke Patients for Stroke Etiology at a Comprehensive Stroke Center

Predicting Ischemic and Bleeding Risk in Patients after PCI on DAPT: An Individualized Patient Centered Machine Learning Model

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content